Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.57 |
| ▸ | RAB9A | P51151 | 5/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | RORC | P51449 | 1/20 | 0.42 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5280075 | 0.82 | USP30 (0.42) | SMN1; SMN2RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL5293345 | 0.82 | SMN1; SMN2 (0.63) | SMN1; SMN2RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL5286842 | 0.79 | NOTUM (0.51) | SMN1; SMN2RAB9AALDH1A1MAPTNPC1 | |
| SCHEMBL892695 | 0.78 | SMN1; SMN2 (0.58) | SMN1; SMN2RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL5290844 | 0.77 | MAPT (0.61) | SMN1; SMN2RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL4805 | 0.77 | RAB9A (0.69) | SMN1; SMN2RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL212382 | 0.76 | RAB9A (0.68) | SMN1; SMN2RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL28091339 | 0.76 | RAB9A (0.68) | SMN1; SMN2RAB9AMEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL8880218 | 0.75 | RAB9A (0.66) | SMN1; SMN2RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL8878334 | 0.74 | SMN1; SMN2 (0.65) | SMN1; SMN2RAB9AMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007001335-A2 | RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. (US) | 2007-01-04 | — | — | WO | disclosed |
| US-20060211603-A1 | Ramoplanin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS INC. (US) | 2006-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211603-A1 | Ramoplanin derivatives possessing antibacterial activity | CLSPN, LMAN2, RPN2 | SMN1; SMN2 3894/4885RAB9A 20/4885MEN1 2853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.